Compare RNR & RVTY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | RNR | RVTY |
|---|---|---|
| Founded | 1993 | 1937 |
| Country | Bermuda | United States |
| Employees | N/A | N/A |
| Industry | Property-Casualty Insurers | Biotechnology: Laboratory Analytical Instruments |
| Sector | Finance | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.6B | 13.2B |
| IPO Year | 1995 | N/A |
| Metric | RNR | RVTY |
|---|---|---|
| Price | $276.43 | $110.48 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 16 | 14 |
| Target Price | ★ $296.50 | $113.46 |
| AVG Volume (30 Days) | 342.4K | ★ 1.3M |
| Earning Date | 02-03-2026 | 02-02-2026 |
| Dividend Yield | ★ 0.58% | 0.24% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 34.70 | 1.99 |
| Revenue | ★ $12,214,870,000.00 | $2,813,367,000.00 |
| Revenue This Year | N/A | $5.33 |
| Revenue Next Year | N/A | $3.03 |
| P/E Ratio | ★ $7.91 | $57.55 |
| Revenue Growth | N/A | ★ 3.37 |
| 52 Week Low | $219.00 | $81.36 |
| 52 Week High | $285.26 | $128.29 |
| Indicator | RNR | RVTY |
|---|---|---|
| Relative Strength Index (RSI) | 53.57 | 55.71 |
| Support Level | $272.02 | $110.17 |
| Resistance Level | $278.46 | $118.21 |
| Average True Range (ATR) | 5.52 | 4.15 |
| MACD | -0.15 | 0.17 |
| Stochastic Oscillator | 64.82 | 56.08 |
RenaissanceRe Holdings Ltd provides reinsurance and insurance solutions and related services. The company's core products include property, casualty and specialty reinsurance. Revenue is derived from three sources: net premiums earned from the insurance and insurance products sold; net investment income from the investment of capital funds and cash; and other income from the company's joint ventures, advisory services, and other items. The reportable segments of the company are the Property segment which includes catastrophe and other property reinsurance, and the Casualty and Specialty segment which is comprised of casualty and specialty reinsurance. It derives a majority of its revenue from the Casualty and specialty segment.
Revvity is a global life sciences and diagnostics company formed in 2023 following the rebranding of PerkinElmer. The company operates in two segments: life sciences, which provides reagents and instruments for biopharma and academic research, and signals software, and diagnostics, which offers tools in immunodiagnostics and newborn and reproductive health. Revvity's products and services are sold worldwide, with major markets in the US, Europe, and China.